Pharma.Aero welcomes the Rhenus Group and KatalX as an associate partner.
The international cross-industry platform fosters collaboration among Life Science and MedTech shippers, certified cargo communities, airport operators and other air cargo industry stakeholders. Its members and associate partners jointly initiate and participate in projects that focus on end-to-end supply chain visibility and address challenges faced by the Life Science and MedTech industry.
Frank Van Gelder, Secretary General of Pharma.Aero, welcomes Rhenus and KatalX to the organization and its future projects.
“With onboarding Rhenus, with a clear and determined Life Science and MedTech vision multi modal, we are enlarging the group of driven full members, that collaborate beyond their own programs to ensure the overall improvement of the industry.
As we drive innovation and engage new projects on the next generation technologies, our new associate partner KatalX matches our common ambition in collaboration and visibility through advanced digital analytics.”
Stephan Dülk, Global Head of Life Sciences and Healthcare at Rhenus Air & Ocean:
“Joining Pharma.Aero provides a great platform and visibility for Rhenus to collaborate with the different stakeholders in the life sciences & healthcare supply chain and to share, learn and grow in this segment. It is a privilege to be part of a global community like Pharma.Aero, working towards continuously improving the standards and defining customer end-to-end solutions across all related fields and business markets. The platform allows us to align with Rhenus global life sciences and healthcare strategy and our vision that it is all about the patient safety.”
Damien de Chillaz, CEO and Co-Founder of KatalX:
“We created KatalX to bridge the visibility and collaboration gaps in supply chains, starting with vital ones where real-time control end-to-end is absolutely mission critical. We see this as a foundation for Trust, hence our mission: Catalyzing Trust in Supply Chains.
We are truly honoured to join Pharma.Aero and have been inspired by its cross-industry leadership from the very early days of KatalX, at the time of Project Sunrays and the challenges of Covid-19 Vaccine logistics. We really look forward to engaging with members and associate partners on projects like Cell & Gene Therapy, Vaccine distribution and Sustainability. “
